Li Lihong, Yao Mengfei, Li Luyuan, Shi Susheng, Song Yan
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
J Pathol Clin Res. 2025 Sep;11(5):e70040. doi: 10.1002/2056-4538.70040.
In this study, we explored the genomic underpinnings of synchronous endometrial and ovarian/fallopian tube carcinoma (SEOC) and synchronous cervical and ovarian/fallopian tube carcinoma (SCOC), focusing on their clonal relationships to discern whether these malignancies represent dual primary tumors (DPTs) or have metastatic origins. We established a cohort comprising 54 SEOC patients and 7 SCOC patients. After selection, 17 patients (12 SEOC and 5 SCOC) underwent comprehensive analysis via whole-exome sequencing. The study encompassed a diverse array of histological subtypes, including high-grade serous carcinoma (HGSC) or uterine serous carcinoma (USC), endometrioid carcinoma exhibiting papillary/mucinous features, dedifferentiated carcinoma (DC), clear cell carcinoma (CCC), HPV-associated cervical squamous cell carcinoma, and HPV-independent cervical adenocarcinoma. Analysis revealed that 58.3% (7 of 12) of SEOC cases and all SCOC cases demonstrated shared mutations. This suggests a clonal relationship and supports a metastatic origin for these tumors. Notably, metastatic SEOC instances included co-occurrences of USC and HGSC in both the endometrium and the ovaries/fallopian tubes, endometrial and ovarian CCC, concurrent endometrioid endometrial carcinoma (EEC) and endometrioid ovarian carcinoma (EOC) with mucinous metaplasia, as well as cases of endometrial DC with ovarian CCC, and both EEC and ovarian DC. Among the SEOC cases classified as metastatic, patients with high-grade tumors and advanced ovarian stage succumbed to their disease, whereas the remainder survived without relapse. In the SCOC cohort, one patient died from the disease. The favorable survival outcomes across varied histotypes suggest that a stage upgrade may not be warranted. Given the favorable clinical outcomes observed, the term 'trans-tubal spread' may be more appropriate than 'metastasis' in this context to prevent potential overtreatment. Directionality analysis revealed a bidirectional pattern of trans-tubal spread between the uterus/cervix and ovary/fallopian tubes. The presence of dedifferentiated carcinoma confirms the manifestation of dedifferentiation during spread. These findings lend support to the trans-tubal implantation hypothesis and contribute novel insights into the molecular mechanisms underlying tumor dissemination in SEOC and SCOC.
在本研究中,我们探究了同步性子宫内膜癌和卵巢/输卵管癌(SEOC)以及同步性宫颈癌和卵巢/输卵管癌(SCOC)的基因组基础,重点关注它们的克隆关系,以确定这些恶性肿瘤是代表双原发性肿瘤(DPT)还是具有转移起源。我们建立了一个包含54例SEOC患者和7例SCOC患者的队列。经过筛选,17例患者(12例SEOC和5例SCOC)通过全外显子测序进行了全面分析。该研究涵盖了多种组织学亚型,包括高级别浆液性癌(HGSC)或子宫浆液性癌(USC)、具有乳头/黏液特征的子宫内膜样癌、去分化癌(DC)、透明细胞癌(CCC)、HPV相关的宫颈鳞状细胞癌以及HPV非依赖性宫颈腺癌。分析显示,58.3%(12例中的7例)的SEOC病例和所有SCOC病例表现出共享突变。这表明存在克隆关系,并支持这些肿瘤具有转移起源。值得注意的是,转移性SEOC病例包括子宫内膜和卵巢/输卵管中同时出现的USC和HGSC、子宫内膜和卵巢CCC、同时存在的子宫内膜样子宫内膜癌(EEC)和伴有黏液化生的子宫内膜样卵巢癌(EOC),以及子宫内膜DC与卵巢CCC、EEC和卵巢DC同时存在的病例。在分类为转移性的SEOC病例中,高级别肿瘤和晚期卵巢分期的患者死于疾病,而其余患者存活且无复发。在SCOC队列中,有1例患者死于该疾病。不同组织学类型患者良好的生存结果表明可能无需进行分期升级。鉴于观察到的良好临床结果,在这种情况下,术语“经输卵管播散”可能比“转移”更合适,以防止潜在的过度治疗。方向性分析揭示了子宫/宫颈与卵巢/输卵管之间经输卵管播散的双向模式。去分化癌的存在证实了播散过程中去分化的表现。这些发现支持了经输卵管植入假说,并为SEOC和SCOC中肿瘤播散的分子机制提供了新的见解。